Intestinal ischaemia adverse event reports that record this term

Kind of term: MedDRA preferred term

What a report is

A report is not proof that the drug was the cause of the event.

FDA says:

Adverse event reports submitted to FDA do not undergo extensive validation or verification. Therefore, a causal relationship cannot be established between product and reactions listed in a report. While a suspected relationship may exist, it is not medically validated and should not be the sole source of information for clinical decision making or other assumptions about the safety or efficacy of a product. Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.
Source: openFDA, Drug Adverse Event Overview, section "Responsible use of the data". The site read the page on 2 Oct 2026. The data have the reports that FDA received through 30 Jun 2026.

FDA also says:

There is no certainty that the reported event (adverse event or medication error) was actually due to the product. FDA does not require that a causal relationship between a product and event be proven, and reports do not always contain enough detail to properly evaluate an event. The information in these reports has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of these events.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated.
Source: openFDA, Response of the drug event API (meta.disclaimer). The site read the page on 2 Oct 2026.

Not medical advice. This site counts what was reported to FDA. Questions about a medicine or device belong with a pharmacist or clinician.

Reports on file

From January 2004 to June 2026, FDA received 5,387 adverse event reports that record the MedDRA preferred term Intestinal ischaemia. The person who codes a report selects the term that agrees best with the description of the reporter.

FDA received 384 reports in the 12 months to June 2026 and 294 in the 12 months before. FDA releases FAERS data every quarter, so the newest months are not complete. They grow in later releases.

By reports in the 12 months to June 2026, this term was number 1,119 of 1,436 reaction terms with a page. Of the 1,332,454 drug reports that FDA received in the 12 months to June 2026, 384 (under 0.1%) record this term. Reports for male patients were 42.4% of the reports that record this term and 34.6% of all drug reports.

The number of people who use the product is not in the data. A count is not a rate.

MedDRA

The Medical Dictionary for Regulatory Activities. The person who codes a report selects the preferred term that agrees best with the description of the reporter. FDA does not publish the description.

Data version

openFDA FAERS release of 29 Oct 2026. Reports received through 30 Jun 2026.

Drugs in these reports

The table has the 80 drug pages with 25 or more reports that record this term. The rows are in order of name. A drug page with fewer reports for this term is not in the table. The counts are the counts that the site keeps for each reaction term, and a count can be lower than the count of FDA.

FDA says:

Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

Importantly, the AEMS data by themselves are not an indicator of the safety profile of the drug or biologic.
Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of 11 Mar 2026. The site read the page on 2 Oct 2026.

Drugs that the reports with the term Intestinal ischaemia name as a suspect product, in order of name
Drug	Class	Reports with this term
Acetaminophen		41
Amlodipine	Calcium channel blocker	79
Aspirin	Nonsteroidal anti-inflammatory drug	52
Atenolol	beta-Adrenergic blocker	28
Atorvastatin		37
Avastin	Vascular endothelial growth factor inhibitor	52
Bevacizumab	Vascular endothelial growth factor inhibitor	70
Capecitabine	Nucleoside metabolic inhibitor	65
Carboplatin	Platinum-based drug	85
Ciprofloxacin	Fluoroquinolone antibacterial	47
Cisplatin	Platinum-based drug	117
Clonazepam	Benzodiazepine	36
Clopidogrel	P2Y12 platelet inhibitor	33
Clozapine	Atypical antipsychotic	96
Clozaril	Atypical antipsychotic	35
Cyclophosphamide	Alkylating drug	38
Cytarabine	Nucleoside metabolic inhibitor	40
Dexamethasone	Corticosteroid	62
Dianeal		42
Diazepam	Benzodiazepine	35
Docetaxel	Microtubule inhibitor	108
Eliquis	Factor Xa inhibitor	40
Epinephrine	Catecholamine	29
Etoposide	Topoisomerase inhibitor	34
Fentanyl	Opioid agonist	56
Fluorouracil	Nucleoside metabolic inhibitor	159
Forane	General anesthetic	44
Furosemide	Loop diuretic	42
Heparin		33
Heparin sodium	Anti-coagulant	27
Humira		98
Ibuprofen	Nonsteroidal anti-inflammatory drug	59
Isoflurane	General anesthetic	41
Keppra		29
Ketamine		27
Keytruda	Programmed death Receptor-1 blocking antibody	35
Lansoprazole	Proton pump inhibitor	34
Levetiracetam		44
Lisinopril	Angiotensin converting enzyme inhibitor	67
Loxapine		28
Meropenem	Penem antibacterial	40
Metformin	Biguanide	65
Methotrexate	Folate analog metabolic inhibitor	83
Methylprednisolone	Corticosteroid	87
Metoprolol	beta-Adrenergic blocker	37
Midazolam	Benzodiazepine	82
Mounjaro	GLP-1 receptor agonist	44
Mycophenolate mofetil	Antimetabolite immunosuppressant	50
Nintedanib	Kinase inhibitor	26
Norepinephrine	Catecholamine	37
Olanzapine	Atypical antipsychotic	28
Omeprazole	Proton pump inhibitor	62
Ondansetron	Serotonin-3 receptor antagonist	55
Oxaliplatin	Platinum-based drug	145
Ozempic	GLP-1 receptor agonist	42
Paclitaxel	Microtubule inhibitor	77
Phenobarbital		52
Phenytoin	Anti-epileptic agent	50
Piperacillin and tazobactam	Penicillin-class antibacterial	27
Potassium chloride	Osmotic laxative	33
Pradaxa	Direct thrombin inhibitor	130
Prednisolone	Corticosteroid	50
Prednisone	Corticosteroid	102
Pregabalin		26
Propofol	General anesthetic	127
Quetiapine	Atypical antipsychotic	60
Remicade	Tumor necrosis factor blocker	29
Revlimid	Thalidomide analog	43
Rituximab	CD20-directed cytolytic antibody	58
Tacrolimus	Calcineurin inhibitor immunosuppressant	43
Taxotere		26
Tramadol		26
Trazodone		34
Valproic acid	Anti-epileptic agent	62
Vasopressin		25
Velcade	Proteasome inhibitor	26
Venlafaxine	Serotonin and norepinephrine reuptake inhibitor	60
Warfarin	Vitamin K antagonist	31
Xarelto	Factor Xa inhibitor	91
Xeloda	Nucleoside metabolic inhibitor	30

The page of each drug has the count of each reaction term in its reaction lookup.

Drug classes in these reports

The table has the 57 pharmacologic classes with 25 or more reports that record this term. The rows are in order of name.

FDA says:

Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

Importantly, the AEMS data by themselves are not an indicator of the safety profile of the drug or biologic.
Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of 11 Mar 2026. The site read the page on 2 Oct 2026.

Pharmacologic classes of the drugs that the reports with the term Intestinal ischaemia name, in order of name
Class	Reports with this term
Alkylating drug	51
Aminoglycoside antibacterial	26
Angiotensin 2 receptor blocker	38
Angiotensin converting enzyme inhibitor	85
Anthracycline topoisomerase inhibitor	32
Anti-coagulant	27
Anti-epileptic agent	137
Antimetabolite immunosuppressant	83
Antirheumatic agent	38
Atypical antipsychotic	296
Benzodiazepine	206
beta-Adrenergic blocker	103
beta2-Adrenergic agonist	36
Biguanide	81
Calcineurin inhibitor immunosuppressant	75
Calcium channel blocker	106
Catecholamine	83
CD20-directed cytolytic antibody	62
Cephalosporin antibacterial	44
Corticosteroid	360
Dihydropyridine calcium channel blocker	31
Direct thrombin inhibitor	133
Epidermal growth factor receptor antagonist	32
Factor Xa inhibitor	159
Fluoroquinolone antibacterial	56
Folate analog	30
Folate analog metabolic inhibitor	126
General anesthetic	202
GLP-1 receptor agonist	150
Hepatitis B virus nucleoside analog reverse transcriptase inhibitor	38
HMG-CoA reductase inhibitor	54
Human immunodeficiency virus nucleoside analog reverse transcriptase inhibitor	26
Interleukin-6 receptor antagonist	27
Janus kinase inhibitor	25
Kinase inhibitor	109
Loop diuretic	46
Microtubule inhibitor	185
Nonsteroidal anti-inflammatory drug	148
Nucleoside metabolic inhibitor	315
Opioid agonist	140
Osmotic laxative	97
P2Y12 platelet inhibitor	43
Penem antibacterial	40
Penicillin-class antibacterial	73
Platinum-based drug	347
Programmed death Receptor-1 blocking antibody	78
Proteasome inhibitor	32
Proton pump inhibitor	158
Serotonin and norepinephrine reuptake inhibitor	91
Serotonin reuptake inhibitor	69
Serotonin-3 receptor antagonist	57
Substance P/Neurokinin-1 receptor antagonist	31
Thalidomide analog	57
Topoisomerase inhibitor	41
Tumor necrosis factor blocker	68
Vascular endothelial growth factor inhibitor	128
Vitamin K antagonist	49

A class with many reports in all has many reports for almost every term.

Reports by month

Reports that record Intestinal ischaemia, by month, five years to June 2026

FDA releases FAERS data every quarter, so the newest months are not complete. They grow in later releases.

Patients in these reports

Age of the patient in the reports that record Intestinal ischaemia
Age	Reports	Share
Under 2	52	1%
2 to 11	61	1.1%
12 to 17	29	0.5%
18 to 44	577	10.7%
45 to 64	1,431	26.6%
65 to 74	1,000	18.6%
75 and over	893	16.6%
Age not given	1,344	24.9%

Sex of the patient in the reports that record Intestinal ischaemia
Sex	Reports	Share
Female	2,551	47.4%
Male	2,286	42.4%
Unknown or not given	550	10.2%

Age and sex are as the report gives them. 37.3% of these reports give the United States as the country.

Terms near this one

These are the next terms in the A to Z list. The links are for navigation.

Official pages

MedWatch Online Voluntary Reporting FormThe online form of FDA for a voluntary report.
MedWatch: The FDA Safety Information and Adverse Event Reporting ProgramThe page of the FDA program that receives reports about drugs and devices.
FDA Adverse Event Monitoring System (AEMS) Public DashboardThe public dashboard of FDA for adverse event reports on drugs and biologics.

The site checked these addresses on 2 Oct 2026. The links open in a new tab.

Cite this page

Reported Reactions. Intestinal ischaemia: adverse event reports that record this term. https://reportedreactions.com/reaction/intestinal-ischaemia/ Source: U.S. Food and Drug Administration, openFDA Drug Adverse Event (FAERS) files, release of 29 Oct 2026. Reports received through 30 Jun 2026.

Where the data come from

The counts come from the openFDA Drug Adverse Event (FAERS) bulk files, release of 29 Oct 2026. The files have the reports that FDA received through 30 Jun 2026. A drug name is the name on the report. The site matches it to a brand name or a generic name of the National Drug Code Directory of 2 Nov 2026. A class is the pharmacologic class (EPC) of the FDA label.

The count has the reports with each spelling of one MedDRA preferred term. The site does not publish a report narrative, a lot number, a detail of a patient or the identity of a reporter. The record of FDA is the authority. See how the site counts reports, the data sources and the corrections page.

Questions

What does Intestinal ischaemia mean in an adverse event report?

It is a MedDRA preferred term. FDA codes the description of a reporter with the MedDRA dictionary. The openFDA files do not have the description itself, and this site does not show it.

Does a drug in the table mean that the drug was responsible for this reaction?

No. FDA says:

No individual drug is connected to any individual reaction.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

When a report lists multiple drugs and multiple reactions, there is no way to conclude from the data therein that a given drug is responsible for a given reaction.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

What does this page tell a person who has this symptom?

This page gives counts of reports. It cannot assess a person. A pharmacist or a clinician can assess a person.

If this is a medical emergency, please call 911.
Source: FDA, MedWatch Online Voluntary Reporting Form. The site read the page on 2 Oct 2026.

To the top of the page